Item(by='divbzero', descendants=None, kids=[24805732], score=None, time=1602886893, title=None, item_type='comment', url=None, parent=24805204, text='This too is my recollection of the initial clinical trial results — shortened course of disease but no indication of improved survival. The new WHO study reinforces the initial evidence but is not new news.<p>Edit: The closest Gilead has come to suggesting a survival advantage from Remdesivir was a <i>comparative</i> analysis presented in July [1]. The analysis was highlighted as inconclusive because it wasn’t a double-blinded placebo-controlled study, which is the gold standard for clinical trials.<p>[1]: <a href="https:&#x2F;&#x2F;www.bloomberg.com&#x2F;news&#x2F;articles&#x2F;2020-07-10&#x2F;gilead-s-remdesivir-linked-to-62-reduction-in-mortality-risk" rel="nofollow">https:&#x2F;&#x2F;www.bloomberg.com&#x2F;news&#x2F;articles&#x2F;2020-07-10&#x2F;gilead-s-...</a>')